Outcomes of Allogeneic Stem-Cell Transplant in Large-Cell Transformation of Mycosis Fungoides
Kunhwa Kim(The University of Texas MD Anderson Cancer Center), Swaminathan P. Iyer(The University of Texas MD Anderson Cancer Center), Yago Nieto(The University of Texas MD Anderson Cancer Center), Carlos A. Torres‐Cabala(The University of Texas MD Anderson Cancer Center), Julia Dai(The University of Texas MD Anderson Cancer Center), Chitra Hosing(The University of Texas MD Anderson Cancer Center), Luis Malpica(The University of Texas MD Anderson Cancer Center), Susan Wu(The University of Texas MD Anderson Cancer Center), Rishabh Lohray(Baylor College of Medicine), Samer A. Srour(Oklahoma City VA Health Care System), Jillian R Gunther(The University of Texas MD Anderson Cancer Center), Bouthaina S. Dabaja(The University of Texas MD Anderson Cancer Center), Jeremy Ramdial(The University of Texas MD Anderson Cancer Center), Ranjit Nair(NewYork–Presbyterian Brooklyn Methodist Hospital), Auris Huen(University of Pennsylvania)
Cited by 0
Related Papers
Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma
|New England Journal of Medicine|2018|584
Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial
|Nature Medicine|2024|452
Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial
|Journal of Clinical Oncology|2013|439
Optimizing Autologous Stem Cell Mobilization Strategies to Improve Patient Outcomes: Consensus Guidelines and Recommendations
|Biology of Blood and Marrow Transplantation|2013|402
Double hit lymphoma: the <scp>MD A</scp> nderson <scp>C</scp> ancer <scp>C</scp> enter clinical experience
|British Journal of Haematology|2014|364